Literature DB >> 3317361

The natural history of hepatitis B.

S Sherlock1.   

Abstract

Hepatitis B infection is acquired through contact with the blood of a person carrying the hepatitis B virus. The carrier rate of HBsAg varies world-wide. In many endemic areas, infection is largely acquired perinatally, while in other areas of high prevalence, transmission occurs during childhood, with intrafamilial spread being particularly important. Subclinical hepatitis B attacks are extremely frequent. The unusual clinical episode diagnosed in the adult tends to be more severe than that for virus A or non-A, non-B infection although the overall picture is similar. A fulminant course may be related to an enhanced immune response, and in such instances, HBsAg titres may be low or undetectable. About 10% of patients suffering an acute attack, more commonly males, will not clear the virus and will become chronic carriers. These may remain 'healthy' or suffer from various grades of chronic hepatitis and cirrhosis. Chronicity is related to impairment of humoral and cell-mediated immunity. There are two phases of hepatitis B infection, the replicative and the integrated, the former being recognized by the presence of hepatitis B viral DNA in serum. Relapses of chronic hepatitis B may be related to conversion from replicative to integrated stages, to spontaneous reactivation, or to super-added virus infection, especially with delta virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3317361

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

1.  Treatment of chronic viral hepatitis with alpha-interferon: A consensus conference report.

Authors: 
Journal:  Can J Infect Dis       Date:  1994-05

2.  HBsAg-induced antigen-specific T and B lymphocyte responses in chronic hepatitis B virus carriers and immune individuals.

Authors:  A Fernan; C J Cayzer; W G Cooksley
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

Review 3.  Viral hepatitis B: clinical and epidemiological characteristics.

Authors:  Gregory S Burns; Alexander J Thompson
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-30       Impact factor: 6.915

4.  Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B.

Authors:  Manoj Kumar; Sanjay Jain; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

5.  Rapid production of neutralizing antibody leads to transient hepadnavirus infection.

Authors:  Yong-Yuan Zhang; Jesse Summers
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 6.  Sexually transmitted viruses.

Authors:  F Rapp
Journal:  Yale J Biol Med       Date:  1989 Mar-Apr

7.  Risk of hepatitis B when migrating from low to high endemic areas.

Authors:  Henrik Bygum Krarup; Karsten Fleischer Rex; Stig Andersen
Journal:  Int J Circumpolar Health       Date:  2020-12       Impact factor: 1.228

8.  High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa.

Authors:  Nokukhanya Msomi; Kogieleum Naidoo; Nonhlanhla Yende-Zuma; Nesri Padayatchi; Kerusha Govender; Jerome Amir Singh; Salim Abdool-Karim; Quarraisha Abdool-Karim; Koleka Mlisana
Journal:  BMC Infect Dis       Date:  2020-11-16       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.